ECOR vs EXAS · rev $25.2M vs rev $2.76B
Electrocore LLC (ECOR) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Electrocore LLC (ECOR) is a medical devices company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported ECOR revenue for 2024-12-31 was $25.2M. Net income was -$11.9M. Revenue was up 57.1% from 2023-12-31 to 2024-12-31. ECOR currently screens at market cap $45.3M.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
ECOR currently screens at market cap $45.3M. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the ECOR and EXAS stock pages for the full models.
Not investment advice.